What is he best known for?
The fields of study he is best known for:
His main research concerns Molecular biology, Antigen, Cancer research, CD19 and Antibody.
His Molecular biology research incorporates elements of Recombinant DNA, MHC class II, Peptide sequence, Epithelial cell adhesion molecule and Monoclonal antibody.
His Antigen research is multidisciplinary, incorporating elements of Single-Chain Fv Antibody, Chaperone and Immunoperoxidase.
His study in Cancer research is interdisciplinary in nature, drawing from both Metastasis, Stem cell and Pancreatic cancer.
His CD19 research integrates issues from Affinities, CD3, B cell and Lymphoma.
Antibody connects with themes related to Virology in his study.
His most cited work include:
- Of mice and men: hybridoma and recombinant antibodies (403 citations)
- VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma (274 citations)
- Editing of the HLA-DR-peptide repertoire by HLA-DM. (248 citations)
What are the main themes of his work throughout his whole career to date?
Molecular biology, Antibody, Antigen, Monoclonal antibody and Cancer research are his primary areas of study.
His Molecular biology research focuses on CD19 in particular.
His work deals with themes such as Amino acid, Computational biology and Recombinant DNA, which intersect with Antibody.
His study explores the link between Antigen and topics such as Immunotherapy that cross with problems in Severe combined immunodeficiency.
The Monoclonal antibody study combines topics in areas such as Cell and Staining.
He has researched Cancer research in several fields, including Cancer, Metastasis, Pancreatic cancer, Immunology and Pathology.
He most often published in these fields:
- Molecular biology (38.76%)
- Antibody (33.01%)
- Antigen (34.93%)
What were the highlights of his more recent work (between 2009-2021)?
- Cancer research (24.40%)
- Antibody (33.01%)
- Immunology (21.05%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Antibody, Immunology, Monoclonal antibody and Molecular biology.
His Cancer research research includes elements of Cancer, Pancreatic cancer, Severe combined immunodeficiency and Cytotoxicity.
The study incorporates disciplines such as Cell culture, Ectodomain and Adenocarcinoma in addition to Antibody.
His Monoclonal antibody study integrates concerns from other disciplines, such as Epitope, Disease and L1.
His Molecular biology study combines topics from a wide range of disciplines, such as Immunohistochemistry, Immunoglobulin G, B-cell lymphoma, CD24 and Immunotherapy.
His Antigen study incorporates themes from Cytotoxic T cell, Moiety and Virology.
Between 2009 and 2021, his most popular works were:
- Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. (169 citations)
- Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. (156 citations)
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma (128 citations)
In his most recent research, the most cited papers focused on:
Gerhard Moldenhauer focuses on Pancreatic cancer, Cancer research, Pathology, Ectodomain and Molecular biology.
His Pancreatic cancer research incorporates themes from Cell growth, Cancer stem cell, Stem cell, Pancreas and In vivo.
His Sulforaphane study in the realm of Cancer research interacts with subjects such as Tumor hypoxia.
His research in Pathology intersects with topics in Wnt signaling pathway and Interstitial matrix.
His Ectodomain research also works with subjects such as
- Antibody that intertwine with fields like Antigen,
- Cell which intersects with area such as Cell biology.
The various areas that he examines in his Molecular biology study include Epitope, Epithelial cell adhesion molecule, Sialic acid and CD24.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
